Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
15.93
+0.13 (0.82%)
At close: Aug 1, 2025, 4:00 PM
15.92
-0.01 (-0.06%)
After-hours: Aug 1, 2025, 7:32 PM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2016 - 2020
2,2002,4082,8803,4986,5094,405
Upgrade
Market Cap Growth
-54.66%-16.40%-17.67%-46.25%47.77%64.01%
Upgrade
Enterprise Value
1,8452,4362,7993,1836,0174,138
Upgrade
Last Close Price
15.9319.3726.8733.0562.4343.06
Upgrade
PS Ratio
3.70678.1211.9614.3847.0750.06
Upgrade
PB Ratio
3.2212.6010.038.3615.929.54
Upgrade
P/TBV Ratio
3.2613.6111.039.0516.479.87
Upgrade
P/FCF Ratio
229.26---44.06-
Upgrade
P/OCF Ratio
35.98---37.99-
Upgrade
EV/Sales Ratio
3.38686.0211.6313.0943.5147.03
Upgrade
EV/FCF Ratio
192.28---40.72-
Upgrade
Debt / Equity Ratio
1.084.461.340.200.060.05
Upgrade
Debt / FCF Ratio
77.17---0.17-
Upgrade
Asset Turnover
0.430.000.330.350.220.20
Upgrade
Quick Ratio
4.986.573.752.672.587.78
Upgrade
Current Ratio
5.156.743.952.922.637.92
Upgrade
Return on Equity (ROE)
-26.22%-254.98%-59.33%-42.68%-32.36%-23.96%
Upgrade
Return on Assets (ROA)
-5.86%-39.43%-17.58%-15.91%-15.11%-13.35%
Upgrade
Return on Capital (ROIC)
-6.39%-43.84%-21.89%-23.88%-20.31%-16.02%
Upgrade
Earnings Yield
-6.54%-24.90%-7.13%-5.03%-2.16%-1.92%
Upgrade
FCF Yield
0.44%-25.10%-11.48%-5.40%2.27%-2.45%
Upgrade
Buyback Yield / Dilution
-13.90%-12.21%-1.26%-1.62%-3.00%-2.14%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q